Ezetimibe |
Zetia |
Ezetimibe Systematic (IUPAC) name (3R,4S)-1-(4-fluorophenyl)- 3-((3S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4- (4-hydroxyphenyl)-2-azetidinone Identifiers CAS number 163222-33-1 ATC code C10AX09 PubChem 150311 DrugBank APRD00619 Chemical data Formula C24H21NF2O3 Mol. weight 409.4 g.mol-1 Pharmacokinetic data Bioavailability 35–65% Protein binding >90% Metabolism Intestinal wall, hepatic Half life 19–30 hours Excretion Renal 11%, faecal 78% ...
Wikipedia - [full article]
Ezetimibe Clinical Trials
- A Study to Evaluate Ezetimibe in Korean Patients with Primary Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00157911 - Active, not recruiting
Hypercholerolemia
- Effect of TAK-475 With or Without Ezetimibe Versus Ezetimibe Alone in Patients With Primary Dyslipidemia Needing to Reduce Their Low-Density Cholesterol (“Bad” Cholesterol).
ClinicalTrials.gov Identifier: NCT00268697 - Active, not recruiting
Hyperlipidemia; Hypercholesterolemia
- Ezetimibe (+) Simvastatin Vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients
ClinicalTrials.gov Identifier: NCT00157924 - Active, not recruiting
Hypercholesterolemia
- Safety, Effectiveness, and Tolerability of Ezetimibe Combined with Statins for the Treatment of High Cholesterol in HIV Infected Adults
ClinicalTrials.gov Identifier: NCT00099684 - Active, not recruiting
HIV Infections
- To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 Mg.
ClinicalTrials.gov Identifier: NCT00276458 - Recruiting
Hypercholesterolemia
- To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 Mg.
ClinicalTrials.gov Identifier: NCT00276484 - Recruiting
Hypercholesterolemia
- IMPROVE-IT: Examining Outcomes in Subjects with Acute Coronary Syndrome:Vytorin (Ezetimibe/Simvastatin) Vs Simvastatin
ClinicalTrials.gov Identifier: NCT00202878 - Recruiting
Hypercholesterolemia; Myocardial Infarction
- LDL Receptor Under Ezetimibe and Simvastatin
ClinicalTrials.gov Identifier: NCT00317993 - Active, not recruiting
Healthy Men
- Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00385658 - Active, not recruiting
Dyslipidemia
- A 12 Week Study to Assess the Effectiveness of an Investigational Cholesterol-Lowering Drug in Patients That Have Been Hospitalized for a Possible Heart Problem
ClinicalTrials.gov Identifier: NCT00132717 - Active, not recruiting
Hypercholesterolemia
- EASEGO-Study - Doubling of Atorvastatin/Simvastatin or INEGY in Pts with Hypercholesterolemia and CAD
ClinicalTrials.gov Identifier: NCT00166530 - Active, not recruiting
Arthersclerosis
- A Study of Ezetimibe Plus Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00129402 - Completed
Hypercholesterolemia
- Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-Lowering Strategy
ClinicalTrials.gov Identifier: NCT00299884 - Recruiting
Dyslipidemia; Vascular Disease
- Effect of Ezetimibe on Flow-Mediated Brachial Artery Reactivity in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00376246 - Recruiting
Endothelial Dysfunction
- SHARP: Study of Heart and Renal Protection
ClinicalTrials.gov Identifier: NCT00125593 - Active, not recruiting
Kidney Failure, Chronic
- Ezetimibe (+) Simvastatin Vs. Atorvastatin Comparative Study
ClinicalTrials.gov Identifier: NCT00166504 - Completed
Hypercholesterolemia
- A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
ClinicalTrials.gov Identifier: NCT00203476 - Recruiting
Hyperlipidemia; Hypercholesterolemia
- Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
ClinicalTrials.gov Identifier: NCT00397657 - Recruiting
Atherosclerosis
- Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for CHD
ClinicalTrials.gov Identifier: NCT00418834 - Recruiting
Hypercholesterolemia
- 12-Week Open-Label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
ClinicalTrials.gov Identifier: NCT00525824 - Recruiting
Hypercholesterolemia; Coronary Heart Disease; Atherosclerosis
- Study of the Inflammatory Activity in Diabetic Patients With Stable Angina Treated With Simvastatin and Ezetimibe
ClinicalTrials.gov Identifier: NCT00474123 - Recruiting
Diabetes; Stable Angina
- Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
ClinicalTrials.gov Identifier: NCT00485121 - Recruiting
Metabolic Syndrome; Obesity; Coronary Artery Disease
- Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons
ClinicalTrials.gov Identifier: NCT00481351 - Not yet recruiting
Coronary Heart Disease
- Ezetimibe/Simvastatin in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00409773 - Recruiting
Hypercholesterolemia; Metabolic Syndrome
- Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia
ClinicalTrials.gov Identifier: NCT00099996 - Completed
Heart Diseases; Metabolism, Inborn Errors
- Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
ClinicalTrials.gov Identifier: NCT00475826 - Recruiting
Heterozigous Familial Hypercholesterolemia
- Ezetimibe and Simvastatin in Dyslipidemia of Diabetes
ClinicalTrials.gov Identifier: NCT00157482 - Completed
Type 2 Diabetes
- Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis
ClinicalTrials.gov Identifier: NCT00560170 - Recruiting
Atherosclerosis
- A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk
ClinicalTrials.gov Identifier: NCT00479713 - Recruiting
Hypercholesterolemia
- A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease
ClinicalTrials.gov Identifier: NCT00535405 - Recruiting
Hypercholesterolemia
- The Effects of Ezetimibe/Simvastatin Tablet 10/20 mg Versus Doubling the Dose of Simvastatin 20 mg [Simvastatin 40 mg] in High Cholesterol and Coronary Heart Disease (Study P04039)
ClinicalTrials.gov Identifier: NCT00423579 - Recruiting
Hypercholesterolemia; Coronary Disease
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol.
ClinicalTrials.gov Identifier: NCT00271817 - Recruiting
Hypercholesterolemia
- TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)
ClinicalTrials.gov Identifier: NCT00328523 - Completed
Hypercholesterolaemia; Hyperlipidaemia
- Ezetimibe Added to Statin Therapy (EASY) Study
ClinicalTrials.gov Identifier: NCT00395473 - Completed
Hypercholesterolemia
- A Clinical Trial Comparing Torcetrapib/Atorvastatinto Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
ClinicalTrials.gov Identifier: NCT00267267 - Terminated
Hyperlipidemia; Dyslipidemia
- Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
ClinicalTrials.gov Identifier: NCT00189085 - Completed
Metabolic Syndrome
- Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe
ClinicalTrials.gov Identifier: NCT00457275 - Completed
Hypercholesterolemia
- Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation
ClinicalTrials.gov Identifier: NCT00466401 - Completed
Hypercholesterolemia
- Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
ClinicalTrials.gov Identifier: NCT00461968 - Completed
Cholesterol, LDL
- Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
ClinicalTrials.gov Identifier: NCT00185107 - Completed
Hypercholesterolemia
- A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
ClinicalTrials.gov Identifier: NCT00195793 - Completed
Hyperlipidemia
- Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone
ClinicalTrials.gov Identifier: NCT00171288 - Completed
Dyslipidemia
- A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00349284 - Completed
Hyperlipidemia Combined
- The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00405067 - Completed
Hypercholesterolemia
- Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients
ClinicalTrials.gov Identifier: NCT00551876 - Completed
Diabetes Mellitus, Type 2
- A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease
ClinicalTrials.gov Identifier: NCT00551447 - Completed
Coronary Disease
- Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578AM3)
ClinicalTrials.gov Identifier: NCT00552097 - Completed
Atherosclerosis; Hypercholesterolemia; Hyperlipoproteinemia Type II
- Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00319449 - Completed
Hypercholesterolemia; Coronary Arteriosclerosis
- SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
ClinicalTrials.gov Identifier: NCT00045812 - Completed
Lipoidosis
- The Efficacy, Safety, and Tolerability of Ezetimibe Added to Ongoing Atorvastatin Therapy in the Treatment of Patients With Primary Hypercholesterolemia and Coronary Heart Disease (Study P03740)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00202904 - Completed
Hypercholesterolemia; Coronary Heart Disease
- Comparative Efficacy Evaluation of Lipids when Treated with Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
ClinicalTrials.gov Identifier: NCT00079638 - Completed
Dyslipidemia; Coronary Heart Disease; Atherosclerosis; Stroke; Diabetes
- Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
ClinicalTrials.gov Identifier: NCT00423488 - Completed
Hypercholesterolemia; Diabetes Mellitus, Type 2; Coronary Disease

Not Signed In -


